Higher-Risk Myelodysplastic Syndrome (HR-MDS)
1 clinical trials · Condition
◉ Watch Higher-Risk Myelodysplastic Syndrome (HR-MDS)
| Record | Firm | Date |
|---|---|---|
| Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications (NCT02649790) | Karyopharm Therapeutics Inc | 2016-01-01 |
Track Higher-Risk Myelodysplastic Syndrome (HR-MDS) automatically
Every clearance here is in the API, with alerts when new ones post.